Lead Scoring for Healthcare Sales: Separating What Works From What Sounds Right | NPLUS Global

Lead scoring has become one of those practices everyone assumes is settled science. Import a framework from a generic B2B playbook, plug in your CRM fields, assign some points, and let the model tell SDRs who to call first. The problem is that most of these frameworks were built for software buyers with flat org charts and fast decision cycles — not for hospital systems, physician groups, or medical device buying committees where the person who opens your email is rarely the person who signs the PO.

These myths persist because they're easy to implement and hard to argue against in a planning meeting. Nobody gets fired for adding "more data" to a model. But in healthcare specifically, the gap between a scoring model that looks sophisticated and one that actually protects SDR time is wide — and most teams don't find out which side they're on until quota season.

Myth: More data points always make a scoring model more accurate.

Fact: Past a certain point, adding fields without weighting them against actual conversion history just adds noise the model treats as signal. A healthcare-specific model with five well-chosen, causally linked variables — specialty, facility type, role seniority, recent procurement activity, engagement recency — will consistently outperform a twenty-field model built by committee. The instinct to "capture everything" usually comes from marketing ops wanting flexibility, not from evidence that more inputs improve prediction.

Myth: Firmographic fit is a reliable stand-in for buying intent.

Fact: Knowing that a contact sits inside a 400-bed hospital system with the right specialty mix tells you they're a plausible fit — it tells you almost nothing about whether they're actively evaluating anything right now. Healthcare buying cycles are long and quiet for most of their duration, so firmographic-heavy models tend to produce lists full of technically-qualified accounts that have shown zero recent behavior. SDRs end up calling into silence because the score rewarded "who they are" over "what they're doing."

Myth: A high lead score means the contact is sales-ready.

Fact: In healthcare specifically, the people who generate the most trackable engagement — downloading compliance guides, attending webinars, opening every email from a hospital's procurement or credentialing team — are frequently gatekeepers, not champions. They score high because they're active, not because they have authority to move a deal. A model that doesn't separate engagement volume from decision-making power will keep sending SDRs to well-informed people who can't say yes.

Myth: Once the scoring model is built, it can run untouched for a year or more.

Fact: Healthcare organizations have unusually high role turnover and reorganization frequency — service lines merge, credentialing changes, physicians move between affiliated groups — and a static model quietly starts scoring ghosts. Teams that work closely with provider and facility data, including data ops groups like ours at NPLUS Global, see this decay show up first as a rise in "high score, no response" leads long before anyone notices in the dashboards. A quarterly recalibration against actual close-won and close-lost data isn't optional maintenance; it's the difference between a model that helps and one that's actively misdirecting SDR hours.

Myth: SDRs should manually re-verify every scored lead before reaching out.

Fact: If your SDRs are re-qualifying leads the model already qualified, the scoring system isn't saving anyone time — it's just adding a checkpoint. The entire point of a well-tuned model is that SDRs trust the filter and spend their limited hours on context and message relevance, not redundant verification. If reps don't trust the score enough to skip manual checks, that's a signal the model needs fixing, not a justification for keeping the manual layer permanently.

Myth: Marketing and sales can share one universal lead score.

Fact: Marketing's definition of "engaged" and sales' definition of "ready to talk" are rarely the same threshold, especially in healthcare where a marketing win (a physician downloading clinical evidence) and a sales win (a service-line director requesting pricing) reflect completely different stages of a much longer, multi-stakeholder process. When both teams use one score, SDRs end up chasing marketing's definition of success instead of sales' — following up on leads that look active but have no near-term budget authority attached. Separate MQL and SQL thresholds, tied to different behaviors, keep SDR time pointed at the second group.

Myth: Negative signals matter less than positive engagement when scoring leads.

Fact: In most healthcare data sets, negative and disqualifying signals are actually more actionable than another point of positive engagement, because they let you demote or drop leads before an SDR ever wastes a call on them. A taxonomy mismatch between a contact's listed specialty and their actual NPI record, a bounced or reassigned role, or a hard opt-out from a compliance-related list should actively subtract from a score rather than just sitting unused. Models that only add points and never subtract them tend to accumulate a long tail of technically-qualified, practically-dead leads that keep resurfacing in SDR queues month after month.